缺氧负荷指导阻塞性睡眠呼吸暂停患者的CPAP治疗分配:ISAACC试验事后分析
该研究为ISAACC试验的事后分析,纳入非嗜睡且合并急性冠脉综合征的OSA患者,按基线缺氧负荷中位数(73.1%min·h-1)分为高、低负荷组,评估CPAP对心血管结局的影响是否依赖基线缺氧负荷。结果显示高缺氧负荷组CPAP显著降低心血管事件发生率(HR 0.57,95%CI 0.34-0.96),低负荷组CPAP治疗者心血管结局风险呈升高趋势(HR 1.33,95%CI 0.79-2.25),且治疗效应随基线缺氧负荷呈剂量-反应关系。
要点
- 高缺氧负荷的OSA患者接受CPAP可显著降低心血管事件风险。
- 低缺氧负荷患者接受CPAP未见心血管获益,甚至呈风险升高趋势。
- 缺氧负荷可能有助于筛选可从CPAP治疗中获益的OSA患者。
核心结论
- 在非嗜睡且合并急性冠脉综合征的OSA患者中,高基线缺氧负荷与CPAP对心血管预后的长期保护效应相关。
研究设计与样本
- ISAACC试验的事后分析,纳入经呼吸多导仪诊断OSA(AHI≥15次·h-1)的非嗜睡急性冠脉综合征患者。
- 患者随机分配至CPAP组或常规治疗组,随访至少1年。
- 缺氧负荷按自动识别的所有去饱和事件曲线下总面积除以总睡眠时间计算。
- 按基线缺氧负荷中位数(73.1%min·h-1)将患者分为高负荷组和低负荷组。
- 采用多变量Cox回归模型评估CPAP对心血管结局的影响是否依赖基线缺氧负荷水平。
主要发现
- 治疗臂与缺氧负荷类别之间存在显著交互作用。
- 高缺氧负荷组中,CPAP治疗与心血管事件发生率显著降低相关(HR 0.57,95%CI 0.34-0.96)。
- 低缺氧负荷组中,CPAP治疗患者心血管结局风险较常规治疗组呈升高趋势(HR 1.33,95%CI 0.79-2.25)。
- 治疗效应随基线缺氧负荷水平呈剂量-反应关系。
关键数值与推荐
- OSA诊断标准:呼吸多导仪测得AHI≥15次·h-1。
- 缺氧负荷分组阈值:基线缺氧负荷中位数73.1%min·h-1。
- 高缺氧负荷组CPAP对心血管事件的HR为0.57(95%CI 0.34-0.96)。
- 低缺氧负荷组CPAP对心血管事件的HR为1.33(95%CI 0.79-2.25)。
临床怎么用
- 对于非嗜睡且合并急性冠脉综合征的OSA患者,可考虑计算基线缺氧负荷以识别CPAP心血管获益人群。
- 高缺氧负荷患者可能从CPAP治疗中获得心血管预后改善。
- 低缺氧负荷患者CPAP的心血管获益不明确,治疗决策需个体化权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypoxic burden (HB) has emerged as a strong predictor of cardiovascular risk in obstructive sleep apnoea (OSA). We aimed to assess the potential of HB to predict the cardiovascular benefit of treating OSA with continuous positive airway pressure (CPAP). METHODS: This was a post hoc analysis of the ISAACC trial (ClinicalTrials.gov: NCT01335087) including non-sleepy patients with acute coronary syndrome (ACS) diagnosed with OSA (apnoea-hypopnoea index ≥15 events·h-1) by respiratory polygraphy. Patients were randomised to CPAP or usual care and followed for a minimum of 1 year. HB was calculated as the total area under all automatically identified desaturations divided by total sleep time. Patients were categorised as having high or low baseline HB according to the median value (73.1%min·h-1). Multivariable Cox regression models were used to assess whether the effect of CPAP on the incidence of cardiovascular outcomes was dependent on the baseline HB level. RESULTS: The population (362 patients assigned to CPAP and 365 patients assigned to usual care) was middle-aged (mean age 59.7 years), overweight/obese and mostly male (84.5%). A significant interaction was found between the treatment arm and the HB categories. In the high HB group, CPAP treatment was associated with a significant reduction in the incidence of cardiovascular events (HR 0.57, 95% CI 0.34-0.96). In the low HB group, CPAP-treated patients exhibited a trend toward a higher risk of cardiovascular outcomes than those receiving usual care (HR 1.33, 95% CI 0.79-2.25). The differential effect of the treatment depending on the baseline HB level followed a dose-response relationship. CONCLUSION: In non-sleepy ACS patients with OSA, high HB levels were associated with a long-term protective effect of CPAP on cardiovascular prognosis.
引用
- Pinilla L, Esmaeili N, Labarca G, et al. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial. Eur Respir J. 2023. PMID: 37734857. doi:10.1183/13993003.00828-2023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。